$835.6 M

AXSM Mkt cap, 22-May-2019
Axsome Therapeutics Net income (Q1, 2019)-10.6 M
Axsome Therapeutics EBIT (Q1, 2019)-10.4 M
Axsome Therapeutics Cash, 31-Mar-201942.6 M

Axsome Therapeutics Income Statement

Annual

USDFY, 2016FY, 2017FY, 2018

R&D expense

21.2m20.0m23.5m

General and administrative expense

6.3m7.2m9.4m

Operating expense total

27.5m27.2m32.8m

EBIT

(27.5m)(27.2m)(32.8m)

Net Income

(27.2m)(28.9m)(31.0m)

Quarterly

USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

R&D expense

4.5m5.3m5.6m6.0m5.0m4.5m4.8m5.6m6.0m7.6m

General and administrative expense

1.4m1.5m1.6m1.7m1.7m1.8m2.4m2.4m2.2m2.8m

Operating expense total

5.9m6.8m7.2m7.7m6.8m6.3m7.2m8.0m8.2m10.4m

EBIT

(5.9m)(6.8m)(7.2m)(7.7m)(6.8m)(6.3m)(7.2m)(8.0m)(8.2m)(10.4m)

Interest income

15.1k13.2k

Net Income

(5.9m)(6.8m)(7.2m)(8.0m)(7.1m)(6.4m)(4.8m)(8.3m)(8.3m)(10.6m)

Axsome Therapeutics Balance Sheet

Annual

USDFY, 2016FY, 2017FY, 2018

Cash

36.6m34.0m14.0m

Inventories

2.6m

Current Assets

38.0m35.3m15.2m

Total Assets

38.2m35.6m15.4m

Accounts Payable

4.1m3.4m3.7m

Current Liabilities

7.2m12.2m10.8m

Total Liabilities

16.6m18.8m14.4m

Additional Paid-in Capital

69.2m93.3m108.5m

Retained Earnings

(47.6m)(76.6m)(107.6m)

Total Equity

21.6m937.9k

Financial Leverage

1.8 x16.4 x

Axsome Therapeutics Cash Flow

Annual

USDFY, 2016FY, 2017FY, 2018

Net Income

(27.2m)(28.9m)(31.0m)

Depreciation and Amortization

20.5k42.6k48.9k

Inventories

(383.9k)

Accounts Payable

2.2m(645.7k)251.8k

Cash From Operating Activities

(21.3m)(26.5m)(30.1m)

Cash From Investing Activities

(104.6k)(9.9k)(32.7k)

Cash From Financing Activities

10.0m23.9m10.0m

Interest Paid

772.0k

Quarterly

USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Net Income

(5.9m)(12.7m)(19.9m)(8.0m)(15.1m)(21.5m)(4.8m)(13.1m)(21.4m)(10.6m)

Depreciation and Amortization

2.1k5.1k10.7k10.1k20.5k31.3k11.9k23.7k36.7k11.4k

Accounts Payable

(61.9k)1.1m2.0m659.5k(42.5k)(1.1m)439.1k(260.3k)731.9k(253.1k)

Cash From Operating Activities

(3.9m)(9.3m)(14.1m)(6.6m)(13.7m)(20.2m)(6.7m)(14.3m)(20.3m)(9.5m)

Cash From Investing Activities

(10.7k)(22.3k)(98.5k)(2.9k)(6.3k)(9.9k)(14.6k)(24.2k)(32.7k)

Cash From Financing Activities

241.7k7.1m14.7k15.0m15.1m15.2m(693.4k)702.3k1.5m38.2m

Interest Paid

216.7k

Axsome Therapeutics Ratios

USDY, 2019

Financial Leverage

2.5 x

Axsome Therapeutics Employee Rating

0 votes
Culture & Values
N/A
Work/Life Balance
N/A
Senior Management
N/A
Salary & Benefits
N/A
Career Opportunities
N/A
Source